T-cell receptor signal strength and epigenetic control of Bim predict memory CD8
Animals
Bcl-2-Like Protein 11
/ genetics
CD8-Positive T-Lymphocytes
/ cytology
Cell Lineage
/ genetics
Cell Survival
DNA Methylation
/ genetics
Epigenesis, Genetic
Genes, Reporter
Immunologic Memory
/ genetics
Mice, Inbred C57BL
Nuclear Receptor Subfamily 4, Group A, Member 1
/ metabolism
Promoter Regions, Genetic
/ genetics
Receptors, Antigen, T-Cell
/ metabolism
Signal Transduction
Journal
Cell death and differentiation
ISSN: 1476-5403
Titre abrégé: Cell Death Differ
Pays: England
ID NLM: 9437445
Informations de publication
Date de publication:
04 2020
04 2020
Historique:
received:
19
03
2019
accepted:
21
08
2019
revised:
31
05
2019
pubmed:
29
9
2019
medline:
30
6
2021
entrez:
28
9
2019
Statut:
ppublish
Résumé
Most effector CD8
Identifiants
pubmed: 31558776
doi: 10.1038/s41418-019-0410-x
pii: 10.1038/s41418-019-0410-x
pmc: PMC7206134
doi:
Substances chimiques
Bcl-2-Like Protein 11
0
Nr4a1 protein, mouse
0
Nuclear Receptor Subfamily 4, Group A, Member 1
0
Receptors, Antigen, T-Cell
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
1214-1224Subventions
Organisme : NIA NIH HHS
ID : R01 AG033057
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI109810
Pays : United States
Organisme : U.S. Department of Health & Human Services | National Institutes of Health (NIH)
ID : RO1 AI057753
Pays : International
Organisme : NIDDK NIH HHS
ID : R01 DK081175
Pays : United States
Organisme : U.S. Department of Health & Human Services | National Institutes of Health (NIH)
ID : RO1 AG03357
Pays : International
Organisme : NIAID NIH HHS
ID : R01 AI057753
Pays : United States
Organisme : U.S. Department of Health & Human Services | National Institutes of Health (NIH)
ID : RO1 AI109810
Pays : International
Références
D’Cruz LM, Rubinstein MP, Goldrath AW. Surviving the crash: transitioning from effector to memory CD8+ T cell. Semin Immunol. 2009;21:92–8.
doi: 10.1016/j.smim.2009.02.002
pubmed: 19269192
pmcid: 19269192
Kurtulus S, Tripathi P, Hildeman DA. Protecting and rescuing the effectors: Roles of differentiation and survival in the control of memory T cell development. Front Immunol. 2012;3:404.
pubmed: 23346085
Li K-P, et al. Dying to protect: cell death and the control of T- cell homeostasis. Immunol Rev. 2017;277:21–43.
doi: 10.1111/imr.12538
pubmed: 28462527
pmcid: 28462527
Obar JJ, Lefrançois L. Early signals during CD8 T cell priming regulate the generation of central memory cells. J Immunol. 2010;185:263–72.
doi: 10.4049/jimmunol.1000492
pubmed: 20519649
pmcid: 20519649
Joshi NS, et al. Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. Immunity. 2007;27:281–95.
doi: 10.1016/j.immuni.2007.07.010
pubmed: 17723218
pmcid: 17723218
Sarkar S, et al. Strength of stimulus and clonal competition impact the rate of memory CD8 T cell differentiation. J Immunol (Baltim, Md 1950). 2007;179:6704–14.
doi: 10.4049/jimmunol.179.10.6704
Kaech SM, Cui W. Transcriptional control of effector and memory CD8+ T cell differentiation. Nat Rev Immunol. 2012;12:749–61.
doi: 10.1038/nri3307
pubmed: 23080391
pmcid: 23080391
Wherry EJ, et al. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol. 2003;4:225–34.
doi: 10.1038/ni889
pubmed: 12563257
pmcid: 12563257
Masopust D, Vezys V, Marzo AL, Lefrançois L. Preferential localization of effector memory cells in nonlymphoid tissue. Science (80-). 2001;291:2413–7.
doi: 10.1126/science.1058867
Sallusto F, Lenig D, Förster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 1999;401:708–12.
doi: 10.1038/44385
pubmed: 10537110
pmcid: 10537110
Kurtulus S, Tripathi P, Opferman JT, Hildeman DA. Contracting the “mus cells”–does down-sizing suit us for diving into the memory pool? Immunol Rev. 2010;236:54–67.
doi: 10.1111/j.1600-065X.2010.00920.x
pubmed: 20636808
pmcid: 20636808
Weant AE, et al. Apoptosis regulators Bim and Fas function concurrently to control autoimmunity and CD8+ T cell contraction. Immunity. 2008;28:218–30.
doi: 10.1016/j.immuni.2007.12.014
pubmed: 18275832
pmcid: 18275832
Pellegrini M, Belz G, Bouillet P, Strasser A. Shutdown of an acute T cell immune response to viral infection is mediated by the proapoptotic Bcl-2 homology 3-only protein Bim. Proc Natl Acad Sci USA. 2003;100:14175–80.
doi: 10.1073/pnas.2336198100
pubmed: 14623954
pmcid: 14623954
Wojciechowski S, et al. Bim mediates apoptosis of CD127(lo) effector T cells and limits T cell memory. Eur J Immunol. 2006;36:1694–706.
doi: 10.1002/eji.200635897
pubmed: 16761315
pmcid: 16761315
Kurtulus S, et al. Bcl-2 allows effector and memory CD8+ T cells to tolerate higher expression of Bim. J Immunol. 2011;186:5729–37.
doi: 10.4049/jimmunol.1100102
pubmed: 21451108
pmcid: 21451108
Kurtulus S, et al. Bim controls IL-15 availability and limits engagement of multiple BH3-only proteins. Cell Death Differ. 2015;22:174–84.
Koenen P, et al. Mutually exclusive regulation of T cell survival by IL-7R and antigen receptor-induced signals. Nat Commun. 2013;4:1735.
doi: 10.1038/ncomms2719
pubmed: 23591902
pmcid: 23591902
Canté-Barrett K, Gallo EM, Winslow MM, Crabtree GR. Thymocyte negative selection is mediated by protein kinase C- and Ca2+-dependent transcriptional induction of bim [corrected]. J Immunol. 2006;176:2299–306.
doi: 10.4049/jimmunol.176.4.2299
pubmed: 16455986
pmcid: 16455986
Kovalovsky D, et al. β-Catenin/Tcf determines the outcome of thymic selection in response to αβTCR signaling. J Immunol. 2009;183:3873–84.
doi: 10.4049/jimmunol.0901369
pubmed: 19717519
pmcid: 19717519
Daniels MA, Teixeiro E. TCR signaling in T cell memory. Front Immunol. 2015;6:1–10.
Moran AE, et al. T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse. J Exp Med. 2011;208:1279–89.
doi: 10.1084/jem.20110308
pubmed: 21606508
pmcid: 21606508
Wojciechowski S, et al. Bim/Bcl-2 balance is critical for maintaining naive and memory T cell homeostasis. J Exp Med. 2007;204:1665–75.
doi: 10.1084/jem.20070618
pubmed: 17591857
pmcid: 17591857
Hildeman DA, et al. Activated T cell death in vivo mediated by proapoptotic bcl-2 family member bim. Immunity. 2002;16:759–67.
doi: 10.1016/S1074-7613(02)00322-9
pubmed: 12121658
pmcid: 12121658
Chougnet CA, et al. A major role for Bim in regulatory T cell homeostasis. J Immunol. 2011;186:156–63.
doi: 10.4049/jimmunol.1001505
pubmed: 21098226
pmcid: 21098226
Li K-P, et al. Temporal expression of Bim limits the development of agonist-selected thymocytes and skews their TCRβ repertoire. J Immunol. 2017;198:257–69.
doi: 10.4049/jimmunol.1601200
pubmed: 27852740
pmcid: 27852740
McDonald BD, Bunker JJ, Ishizuka IE, Jabri B, Bendelac A. Elevated T cell receptor signaling identifies a thymic precursor to the TCRαβ(+)CD4(‒)CD8β(‒) intraepithelial lymphocyte lineage. Immunity. 2014;41:219–29.
doi: 10.1016/j.immuni.2014.07.008
pubmed: 25131532
pmcid: 25131532
Pobezinsky La, et al. Clonal deletion and the fate of autoreactive thymocytes that survive negative selection. Nat Immunol. 2012;13:569–78.
doi: 10.1038/ni.2292
pubmed: 22544394
pmcid: 22544394
Tai X, et al. Foxp3 transcription factor is proapoptotic and lethal to developing regulatory T cells unless counterbalanced by cytokine survival signals. Immunity. 2013;38:1116–28.
doi: 10.1016/j.immuni.2013.02.022
pubmed: 23746651
pmcid: 23746651
Hutcheson J, Perlman H. Loss of Bim results in abnormal accumulation of mature CD4-CD8-CD44-CD25- thymocytes. Immunobiology. 2007;212:629–36.
doi: 10.1016/j.imbio.2007.05.003
pubmed: 17869640
pmcid: 17869640
Kent WJ, et al. The human genome browser at UCSC. Genome Res. 2002;12:996–1006.
doi: 10.1101/gr.229102
pubmed: 12045153
pmcid: 12045153
León B, Ballesteros-tato A, Randall TD, Lund FE. Prolonged antigen presentation by immune complex-binding dendritic cells programs the proliferative capacity of memory CD8 T cells. J Exp Med. 2014;211:1637–55.
doi: 10.1084/jem.20131692
pubmed: 25002751
pmcid: 25002751
Ballesteros-Tato A, León B, Lee BO, Lund FE, Randall TD. Epitope-specific regulation of memory programming by differential duration of antigen presentation to influenza-specific CD8+ T Cells. Immunity. 2014;41:127–40.
doi: 10.1016/j.immuni.2014.06.007
pubmed: 25035957
pmcid: 25035957
Laugel B, et al. Different T cell receptor affinity thresholds and CD8 coreceptor dependence govern cytotoxic T lymphocyte activation and tetramer binding properties. J Biol Chem. 2007;282:23799–810.
doi: 10.1074/jbc.M700976200
pubmed: 17540778
pmcid: 17540778
Yee C, Savage PA, Lee PP, Davis MM, Greenberg PD. Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers. J Immunol. 1999;162:2227–34.
pubmed: 9973498
pmcid: 9973498
Busch DH, Pamer EG. T cell affinity maturation by selective expansion during infection. J Exp Med. 1999;189:701–10.
doi: 10.1084/jem.189.4.701
pubmed: 9989985
pmcid: 9989985
Crawford F, Kozono H, White J, Marrack P, Kappler J. Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes. Immunity. 1998;8:675–82.
doi: 10.1016/S1074-7613(00)80572-5
pubmed: 9655481
pmcid: 9655481
Hübner A, Barrett T, Flavell RA, Davis RJ. Multisite phosphorylation regulates Bim stability and apoptotic activity. Mol Cell. 2008;30:415–25.
doi: 10.1016/j.molcel.2008.03.025
pubmed: 18498746
pmcid: 18498746
Tripathi P, et al. STAT5 is critical to maintain effector CD8+ T cell responses. J Immunol. 2010;185:2116–24.
doi: 10.4049/jimmunol.1000842
pubmed: 20644163
pmcid: 20644163
Dunkle a, Dzhagalov I, Gordy C, He YW. Transfer of CD8+ T cell memory using Bcl-2 as a marker. J Immunol. 2013;190:940–7.
doi: 10.4049/jimmunol.1103481
pubmed: 23269245
pmcid: 23269245
Ladle BH, et al. De novo DNA methylation by DNA methyltransferase 3a controls early effector CD8+ T-cell fate decisions following activation. Proc Natl Acad Sci. 2016;113:10631–6.
doi: 10.1073/pnas.1524490113
pubmed: 27582468
pmcid: 27582468
Richter-Larrea JA, et al. Reversion of epigenetically mediated BIM silencing overcomes chemoresistance in Burkitt lymphoma. Blood. 2010;116:2531–42.
doi: 10.1182/blood-2010-02-268003
pubmed: 20570860
pmcid: 20570860
Paschos K, et al. Epstein-barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene Bim. PLoS Pathog. 2009;5:e1000492.
doi: 10.1371/journal.ppat.1000492
pubmed: 19557159
pmcid: 19557159
San José-Eneriz E, et al. Epigenetic down-regulation of BIM expression is associated with reduced optimal responses to imatinib treatment in chronic myeloid leukaemia. Eur J Cancer. 2009;45:1877–89.
doi: 10.1016/j.ejca.2009.04.005
pubmed: 19403302
pmcid: 19403302
Paschos K, Parker GA, Watanatanasup E, White RE, Allday MJ. BIM promoter directly targeted by EBNA3C in polycomb-mediated repression by EBV. Nucl Acids Res. 2012;40:7233–46.
doi: 10.1093/nar/gks391
pubmed: 22584624
pmcid: 22584624
Day EK, et al. Rapid CD8+ T cell repertoire focusing and selection of high-affinity clones into memory following primary infection with a persistent human virus: human cytomegalovirus. J Immunol. 2007;179:3203–13.
doi: 10.4049/jimmunol.179.5.3203
pubmed: 17709536
pmcid: 17709536
Kedl RM, Schaefer BC, Kappler JW, Marrack P. T cells down-modulate peptide-MHC complexes on APCs in vivo. Nat Immunol. 2002;3:27–32.
doi: 10.1038/ni742
pubmed: 11731800
pmcid: 11731800
Williams MA, Ravkov EV, Bevan MJ. Rapid culling of the CD4+ T cell repertoire in the transition from effector to memory. Immunity. 2008;28:533–45.
doi: 10.1016/j.immuni.2008.02.014
pubmed: 18356084
pmcid: 18356084
Zehn D, Lee SY, Bevan MJ. Complete but curtailed T-cell response to very low-affinity antigen. Nature. 2009;458:211–4.
doi: 10.1038/nature07657
pubmed: 19182777
pmcid: 19182777
Bushar ND, Corbo E, Schmidt M, Maltzman JS, Farber DL. Ablation of SLP-76 signaling after T cell priming generates memory CD4 T cells impaired in steady-state and cytokine-driven homeostasis. Proc Natl Acad Sci USA. 2010;107:827–31.
doi: 10.1073/pnas.0908126107
pubmed: 20080760
pmcid: 20080760
Krummey SM, et al. Low-affinity memory CD8+ T cells mediate robust heterologous immunity. J Immunol. 2016;196:2838–46.
doi: 10.4049/jimmunol.1500639
pubmed: 26864034
pmcid: 26864034
Smith-garvin JE, et al. T cell receptor signals direct the composition and function of the memory CD8+ T cell pool. Blood. 2010;116:5548–60.
doi: 10.1182/blood-2010-06-292748
pubmed: 20847203
pmcid: 20847203
King CG, et al. T cell affinity regulates asymmetric division, effector cell differentiation, and tissue pathology. Immunity. 2012;37:709–20.
doi: 10.1016/j.immuni.2012.06.021
pubmed: 23084359
pmcid: 23084359
Fassett MS, Jiang W, D’Alise a M, Mathis D, Benoist C. Nuclear receptor Nr4a1 modulates both regulatory T-cell (Treg) differentiation and clonal deletion. Proc Natl Acad Sci. 2012;109:3891–6.
doi: 10.1073/pnas.1200090109
pubmed: 22345564
pmcid: 22345564
Kiss B, Tóth K, Sarang Z, Garabuczi É, Szondy Z. Retinoids induce Nur77-dependent apoptosis in mouse thymocytes. Biochim Biophys Acta-Mol Cell Res. 2015;1853:660–70.
doi: 10.1016/j.bbamcr.2014.12.035
Yao S, et al. Interferon regulatory factor 4 sustains CD8+ T cell expansion and effector differentiation. Immunity. 2013;39:833–45.
doi: 10.1016/j.immuni.2013.10.007
pubmed: 24211184
pmcid: 24211184
Bouillet P, Cory S, Zhang LC, Strasser A, Adams JM. Degenerative disorders caused by Bcl-2 deficiency prevented by loss of Its BH3-only antagonist Bim. Dev Cell. 2001;1:645–53.
doi: 10.1016/S1534-5807(01)00083-1
pubmed: 11709185
pmcid: 11709185
Putcha GV, et al. Induction of BIM, a proapoptotic BH3-only BCL-2 family member, is critical for neuronal apoptosis. Neuron. 2001;29:615–28.
doi: 10.1016/S0896-6273(01)00238-0
pubmed: 11301022
pmcid: 11301022
Nowyhed HN, Huynh TR, Thomas GD, Blatchley A, Hedrick CC. Cutting edge: the orphan nuclear receptor Nr4a1 regulates CD8+ T cell expansion and effector function through direct repression of Irf4. J Immunol. 2015;55798:4–8.
Nayar R, et al. IRF4 regulates the ratio of T-Bet to eomesodermin in CD8+ T cells responding to persistent LCMV infection. PLoS ONE. 2015;10:1–20.
doi: 10.1371/journal.pone.0144826
Nayar R, et al. Graded levels of IRF4 regulate CD8+ T cell differentiation and expansion, but not attrition, in response to acute virus infection. J Immunol. 2014;192:5881–93.
doi: 10.4049/jimmunol.1303187
pubmed: 24835398
pmcid: 24835398
Raczkowski F, et al. The transcription factor interferon regulatory factor 4 is required for the generation of protective effector CD8+ T cells. Proc Natl Acad Sci USA. 2013;110:15019–24.
doi: 10.1073/pnas.1309378110
pubmed: 23980171
pmcid: 23980171
Tagawa H, et al. Genome-wide array-based CGH for mantle cell lymphoma: identification of homozygous deletions of the proapoptotic gene BIM. Oncogene. 2005;24:1348–58.
doi: 10.1038/sj.onc.1208300
pubmed: 15608680
pmcid: 15608680
Zantl N, et al. Frequent loss of expression of the pro-apoptotic protein Bim in renal cell carcinoma: evidence for contribution to apoptosis resistance. Oncogene. 2007;26:7038–48.
doi: 10.1038/sj.onc.1210510
pubmed: 17486061
pmcid: 17486061
Anderton E, et al. Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt’s lymphoma. Oncogene. 2008;27:421–33.
doi: 10.1038/sj.onc.1210668
pubmed: 17653091
pmcid: 17653091
Oltersdorf T, et al. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature. 2005;435:677–81.
doi: 10.1038/nature03579
pubmed: 15902208
pmcid: 15902208
Tripathi P, Mitchell TC, Finkelman F, Hildeman DA. Cutting edge: limiting amounts of IL-7 do not control contraction of CD4+ T cell responses. J Immunol. 2007;178:4027–31.
doi: 10.4049/jimmunol.178.7.4027
pubmed: 17371956
pmcid: 17371956